Group One Trading’s Foundation Medicine, Inc. FMI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-16,100
Closed -$2.2M 5953
2018
Q2
$2.2M Buy
16,100
+5,500
+52% +$500K 0.02% 1074
2018
Q1
$835K Sell
10,600
-30,500
-74% -$2.25M 0.01% 1653
2017
Q4
$2.8M Sell
41,100
-98,900
-71% -$5.13M 0.02% 983
2017
Q3
$5.63M Buy
140,000
+106,000
+312% +$4.09M 0.05% 460
2017
Q2
$1.35M Sell
34,000
-337,800
-91% -$12.4M 0.01% 1229
2017
Q1
$12M Buy
371,800
+6,000
+2% +$150K 0.14% 154
2016
Q4
$6.47M Buy
365,800
+53,400
+17% +$1.15M 0.06% 343
2016
Q3
$7.29M Sell
312,400
-87,800
-22% -$1.99M 0.08% 276
2016
Q2
$7.47M Buy
400,200
+72,200
+22% +$1.3M 0.09% 244
2016
Q1
$5.96M Buy
328,000
+26,500
+9% +$427K 0.08% 282
2015
Q4
$6.35M Sell
301,500
-21,600
-7% -$416K 0.08% 281
2015
Q3
$5.96M Buy
323,100
+222,100
+220% +$5.55M 0.08% 288
2015
Q2
$3.42M Buy
101,000
+51,100
+102% +$2.06M 0.05% 466
2015
Q1
$2.4M Sell
49,900
-2,500
-5% -$113K 0.04% 552
2014
Q4
$1.16M Sell
52,400
-23,800
-31% -$549K 0.02% 989
2014
Q3
$1.45M Buy
76,200
+57,000
+297% +$1.36M 0.02% 881
2014
Q2
$518K Buy
19,200
+4,200
+28% +$106K 0.01% 1622
2014
Q1
$486K Buy
+15,000
New +$487K 0.01% 1659

Group One Trading's FMI Position: Q3 2017 in Review

Group One Trading sold out of Foundation Medicine, Inc. (FMI) in Q3 2017, closing a stake of 42,629 shares — an estimated $1.64M sold.

Group One Trading first reported a position in FMI in Q1 2014 and held it in 13 quarters. The position peaked at $9.56M in Q1 2017. 97 funds tracked by Wall St. Rank hold FMI as of Q3 2017.

  • Group One Trading reported no remaining Foundation Medicine, Inc. position as of Q3 2017 after selling out during the quarter.
  • Group One Trading sold 42,629 Foundation Medicine, Inc. shares in Q3 2017, an estimated $1.64M.
  • Group One Trading first reported a position in Foundation Medicine, Inc. in Q1 2014 and held it in 13 quarters.
  • Group One Trading's Foundation Medicine, Inc. position peaked at $9.56M in Q1 2017.
  • 97 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2017.

Based on Group One Trading's 13F filing for Q3 2017, filed 15 Nov 2017.